HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Fox, P. J. Articles by Zajicek, J. P. Search for Related Content PubMed Articles by Fox, P. J. Articles by Zajicek, J. P.

Cannabis for Multiple Sclerosis

¹ N16, Tamar Science Park, 1 Davy Rd, Plymouth, UK; Email: p.fox{at}plymouth.ac.uk and
² Derriford Hospital, Derriford Rd, Plymouth, UK; Email: john.zajicek{at}phnt.swest.nhs.uk

EXTRACT

Cannabis has a long history of medicinal use going back over 2000 years. Although concerns about its abuse led to its fall from favour in the early years of the last century, there has recently been a resurgence in interest in its therapeutic effects. The pharmacology of the cannabinoid system is being unravelled, with the discovery of specific cannabinoid receptors and endogenous ligands. There are many anectodal reports of multiple sclerosis (MS) sufferers using the drug and reporting beneficial effects on spasticity, pain, tremor and mood. A small number of scientific studies have been carried out in each of these areas. Finally, there is the intriguing possibility from animal research that cannabinoids may be neuroprotective and thus have the potential to modify the course of the disease itself.

HISTORY

The plant Cannabis Sativa (meaning literally ‘sown cannabis’) has been cultivated for a wide variety of uses throughout history. As the ...

[PDF of this article]